Novel Inhibitors Targeting Urease Promote Fungicidal and Antivirulence Effects in Cryptococcus

Area of Science:

• Mycology
• Medicinal Chemistry
• Biochemistry

Background:

• Cryptococcosis is a severe fungal infection caused by Cryptococcus species, often leading to fatal meningitis.
• Urease is a key virulence factor in Cryptococcus, facilitating survival and spread, making it a potential antifungal target absent in humans.

Purpose of the Study:

• To synthesize and evaluate novel urease inhibitors against Cryptococcus growth and urease activity.
• To characterize the inhibition mechanisms and assess the impact of inhibitors on Cryptococcus virulence factors.

Main Methods:

• Synthesis of a library of synthetic urease inhibitors.
• In vitro evaluation of antifungal activity and urease inhibition.
• Enzyme kinetics analysis and molecular dynamic simulations.
• Assessment of capsule thickness, membrane permeability, and melanin production.

Main Results:

• Four lead compounds (AF19, AF36, AF55, AF57) demonstrated fungicidal activity and urease inhibition at micro- to nanomolar concentrations.
• Distinct inhibition mechanisms were elucidated: competitive, noncompetitive, and mixed-type inhibition.
• Inhibitors reduced capsule thickness and increased membrane permeability; AF55 and AF57 also suppressed melanin production.

Conclusions:

• Urease inhibitors AF55 and AF57 show significant promise as anticryptococcal agents.
• These candidates exhibit potent urease inhibition, fungicidal effects, and multi-virulence factor targeting.
• Favorable predicted pharmacokinetic and toxicological profiles support their further development for cryptococcosis treatment.